These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25719834)

  • 1. The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.
    Kumar R; Geuna E; Michalarea V; Guardascione M; Naumann U; Lorente D; Kaye SB; de Bono JS
    Br J Cancer; 2015 Mar; 112(7):1157-65. PubMed ID: 25719834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).
    Bigot F; Castanon E; Baldini C; Hollebecque A; Carmona A; Postel-Vinay S; Angevin E; Armand JP; Ribrag V; Aspeslagh S; Varga A; Bahleda R; Menis J; Gazzah A; Michot JM; Marabelle A; Soria JC; Massard C
    Eur J Cancer; 2017 Oct; 84():212-218. PubMed ID: 28826074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
    Rossi L; Santoni M; Crabb SJ; Scarpi E; Burattini L; Chau C; Bianchi E; Savini A; Burgio SL; Conti A; Conteduca V; Cascinu S; De Giorgi U
    Ann Surg Oncol; 2015 Apr; 22(4):1377-84. PubMed ID: 25234022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
    McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
    Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.
    Dalpiaz O; Ehrlich GC; Mannweiler S; Hernández JM; Gerger A; Stojakovic T; Pummer K; Zigeuner R; Pichler M; Hutterer GC
    BJU Int; 2014 Sep; 114(3):334-9. PubMed ID: 24053693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma?
    Cetin B; Berk V; Kaplan MA; Afsar B; Tufan G; Ozkan M; Isikdogan A; Benekli M; Coskun U; Buyukberber S
    Clin Genitourin Cancer; 2013 Jun; 11(2):141-8. PubMed ID: 23083797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
    Loh J; Wu J; Chieng J; Chan A; Yong WP; Sundar R; Lee SC; Wong A; Lim JSJ; Tan DSP; Soo R; Goh BC; Tai BC; Chee CE
    Br J Cancer; 2023 Apr; 128(8):1514-1520. PubMed ID: 36797357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer.
    Absenger G; Szkandera J; Stotz M; Postlmayr U; Pichler M; Ress AL; Schaberl-Moser R; Loibner H; Samonigg H; Gerger A
    Anticancer Res; 2013 Oct; 33(10):4591-4. PubMed ID: 24123035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients.
    Langsenlehner T; Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Gerger A; Pichler M
    World J Urol; 2015 Nov; 33(11):1661-7. PubMed ID: 25617235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials.
    Bando H; Rubinstein L; Harris P; Yoshino T; Doi T; Ohtsu A; Welch J; Takebe N
    Gastric Cancer; 2017 May; 20(3):481-488. PubMed ID: 27510411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio.
    Kelkitli E; Atay H; Cilingir F; Güler N; Terzi Y; Ozatlı D; Turgut M
    Ann Hematol; 2014 May; 93(5):841-6. PubMed ID: 24337486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated neutrophil to lymphocyte ratio might predict poor prognosis for colorectal liver metastasis after percutaneous radiofrequency ablation.
    Zhang Y; Peng Z; Chen M; Liu F; Huang J; Xu L; Zhang Y; Chen M
    Int J Hyperthermia; 2012; 28(2):132-40. PubMed ID: 22335227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.
    Nakano K; Hosoda M; Yamamoto M; Yamashita H
    Anticancer Res; 2014 Jul; 34(7):3819-24. PubMed ID: 24982408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction.
    Yuan D; Zhu K; Li K; Yan R; Jia Y; Dang C
    J Surg Oncol; 2014 Sep; 110(3):333-40. PubMed ID: 24889121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating VEGFR2+ bone marrow-derived progenitor cells in patients with advanced cancer.
    Massard C; Borget I; Le Deley MC; Taylor M; Gomez-Roca C; Soria JC; Farace F
    Eur J Cancer; 2012 Jun; 48(9):1354-62. PubMed ID: 22370181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
    Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
    Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival.
    Mason M; Maurice C; McNamara MG; Tieu MT; Lwin Z; Millar BA; Menard C; Laperriere N; Milosevic M; Atenafu EG; Mason W; Chung C
    J Neurooncol; 2017 May; 132(3):463-471. PubMed ID: 28332000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-based prognostic indices in malignant pleural mesothelioma.
    Pinato DJ; Mauri FA; Ramakrishnan R; Wahab L; Lloyd T; Sharma R
    J Thorac Oncol; 2012 Mar; 7(3):587-94. PubMed ID: 22307011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive assessment of the prognosis of pancreatic cancer: peripheral blood neutrophil-lymphocyte ratio and immunohistochemical analyses of the tumour site.
    Takakura K; Ito Z; Suka M; Kanai T; Matsumoto Y; Odahara S; Matsudaira H; Haruki K; Fujiwara Y; Saito R; Gocho T; Nakashiro K; Hamakawa H; Okamoto M; Kajihara M; Misawa T; Ohkusa T; Koido S
    Scand J Gastroenterol; 2016; 51(5):610-7. PubMed ID: 26679084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.